Search Results

Containing any of the words

Only of the type

SFDA Highlights Digital Innovation and Support for Innovators at 6th Health Innovation Hackathon News

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel- group study with an open-label period and long-term extension to assess the efficacy and safety of rilzabrutinib in participants with warm autoimmune hemolytic anemia (wAIHA) Drug Clinical Trial

A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients with Iga Nephropathy Receiving Iptacopan on Top of Supportive Care Drug Clinical Trial

A Global Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of mRNA-3705 in Participants with Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency Drug Clinical Trial

DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer (DESTINY BTC01 - D781PC00001) Drug Clinical Trial

A Retrospective Phase IV Study: Use of the clinical decision support tool (CDST) in predicting probability of response to vedolizumab in Middle Eastern Crohn’s Disease patients: the ME-VOICE study (Middle East Vedolizumab Outcomes probability In CDST Evaluation Drug Clinical Trial

Governor of Najran Region Receives CEO of SFDA News

SFDA CEO Meets with Company and Factory Representatives in Najran News

SFDA Organizes Interactive Workshop on AI and Digital Solutions to Enhance Food Safety News

(WU2608) NCMDR Weekly Update Medical Report